Brief: Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results
30/03/2022 21:11
March 30 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS REPORTS FOURTH QUARTER & FULL YEAR 2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.20
Source text for Eikon: ID:nGNXtyy5F
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt